This is not a conspiracy theory. Who to include in a stage III trial is one of the most difficult problems facing pharma management. They aim to make these as broad as possible and lots of drugs have died because the stage III trials were made too open.
If you want to get a good idea of what really goes on in the pharam industry have a read of the “In The Pipeline” blog [1]. Most of the real value is in the comments.
If you want to get a good idea of what really goes on in the pharam industry have a read of the “In The Pipeline” blog [1]. Most of the real value is in the comments.
1. http://blogs.sciencemag.org/pipeline/